UniProtKB/Swiss-Prot Q13769: Variant p.Val579Ile

THO complex subunit 5
Gene: THOC5
Feedback?

Variant information Variant position:

579 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Valine (V) to Isoleucine (I) at position 579 (V579I, p.Val579Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1049534 [ dbSNP | Ensembl ]

Sequence information Variant position:

579 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

683 The length of the canonical sequence.
Location on the sequence:

GTAKLQAAVVLNPGYSSIPP V FQLCLNWKGEKTNSNDDNIR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GTAKLQAAVVLNPGYSSIPPVFQLCLNWKGEKTNSNDDNIR

Mouse                         GTAKLQAAVVLNPGYSSIPPVFRLCLNWKGEKTNSNDDNIR

Rat                           GTAKLQAAVVLNPGYSSIPPVFRLCLNWKGEKTNSNDDNIR

Bovine                        GTAKLQAAVVLNPGYSSIPPIFQLCLNWKGEKTNNNDDNIR

Chicken                       GTAKLQAAVVLNPGYSALPPIFSLCLNWKGERTGSNDDNIR

Xenopus tropicalis            GTAKLNGVVVLNPGYCAVPPVFSLCLNWKGERSSSNDDNIR

Zebrafish                     GTARLLAAVVVNPRYPEVTPLFSLSLLWKGERSGRTDDNLR

Drosophila                    GSAKMECFIRIPSNYPLEMPLWILNVHWNGCLTAQNNSAIK

Fission yeast                 --------------------------------------NIT

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	2 – 683	THO complex subunit 5
Region	247 – 683	Tandem RWD domains
Beta strand	579 – 588

Literature citations
Cloning of a novel, anonymous gene from a megabase-range YAC and cosmid contig in the neurofibromatosis type 2/meningioma region on human chromosome 22q12.
Xie Y.G.; Han F.Y.; Peyrard M.; Ruttledge M.H.; Fransson I.; deJong P.; Collins J.; Dunham I.; Nordenskjold M.; Dumanski J.P.;
Hum. Mol. Genet. 2:1361-1368(1993)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ILE-525 AND ILE-579; A genome annotation-driven approach to cloning the human ORFeome.
Collins J.E.; Wright C.L.; Edwards C.A.; Davis M.P.; Grinham J.A.; Cole C.G.; Goward M.E.; Aguado B.; Mallya M.; Mokrab Y.; Huckle E.J.; Beare D.M.; Dunham I.;
Genome Biol. 5:R84.1-R84.11(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANTS ILE-525 AND ILE-579; The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANTS ILE-525 AND ILE-579;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.